Bilateral fetal mesencephalic grafting in two patients with parkinsonism induced by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) - Wikidata - awgldk - TriplyDB

Bilateral fetal mesencephalic grafting in two patients with parkinsonism induced by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)

Bilateral fetal mesencephalic grafting in two patients with parkinsonism induced by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)

http://www.wikidata.org/entity/Q28202629

about

sameAs

Gene therapy in clinical medicine Foetal Cell Transplantation for Parkinson's Disease: Focus on Graft-Induced Dyskinesia Merging DBS with viral vector or stem cell implantation: "hybrid" stereotactic surgery as an evolution in the surgical treatment of Parkinson's disease Cell Therapy for Parkinson's Disease: New Hope from Reprogramming Technologies Treating Parkinson's disease in the 21st century: can stem cell transplantation compete?Cellular replacement therapy for Parkinson's disease--where we are today?New developments in the surgery for Parkinson's disease.Long-term MRI cell tracking after intraventricular delivery in a patient with global cerebral ischemia and prospects for magnetic navigation of stem cells within the CSF Unilateral transplantation of human primary fetal tissue in four patients with Huntington's disease: NEST-UK safety report ISRCTN no 36485475.Cell therapy in Parkinson's disease Dopaminergic neurons generated from monkey embryonic stem cells function in a Parkinson primate model.Ethics of fetal tissue transplantation Core assessment program for surgical interventional therapies in Parkinson's disease (CAPSIT-PD).AAV2-mediated gene transfer of GDNF to the striatum of MPTP monkeys enhances the survival and outgrowth of co-implanted fetal dopamine neurons.Viral vectors in the treatment of Parkinson's disease.Idiopathic Parkinson's disease: epidemiology, diagnosis and management.Transplantation therapy for Parkinson's disease.Cell survival and clinical outcome following intrastriatal transplantation in Parkinson disease.Studies on the differentiation of dopaminergic traits in human neural progenitor cells in vitro and in vivo.Multiple system atrophy: current and future approaches to management Gene therapy with herpes simplex virus vectors: progress and prospects for clinical neuroscience.Dopamine release from transplanted neural stem cells in Parkinsonian rat striatum in vivo.Fetal tissue transplantation and abortion decisions: a survey of urban women.Lack of functional relevance of isolated cell damage in transplants of Parkinson's disease patients.Region-specific restoration of striatal synaptic plasticity by dopamine grafts in experimental parkinsonism Insulin-like growth factors act synergistically with basic fibroblast growth factor and nerve growth factor to promote chromaffin cell proliferation.Millimeter-scale positioning of a nerve-growth-factor source and biological activity in the brain Stem cell therapy for Parkinson's disease.Alloimmunisation to donor antigens and immune rejection following foetal neural grafts to the brain in patients with Huntington's disease.Dopamine cell transplantation for Parkinson's disease: the importance of controlled clinical trials.Human pluripotent stem cell therapy for Huntington's disease: technical, immunological, and safety challenges human pluripotent stem cell therapy for Huntington's disease: technical, immunological, and safety challenges.Direct reprogramming of human fibroblasts into dopaminergic neuron-like cells.Cell-based therapies for Parkinson disease—past insights and future potential.Neurodegeneration and neuroprotection in Parkinson disease.Positron emission tomography imaging of transplant function.Embryonic stem cells as a cell source for treating Parkinson's disease.Cyclosporin promotes neurorestoration and cell replacement therapy in pre-clinical models of Parkinson's disease Cellular imaging in drug discovery.Neural transplantation in Huntington's disease: the NEST-UK donor tissue microbiological screening program and review of the literature.Imaging the head: functional imaging.

P2860

Q24680275-74311A2C-51BF-448E-A8F4-B45662CF52CF Q26765499-D780897A-8FC2-47AD-AA71-C2878AA486B9 Q26773485-AD3C6C54-E1BD-45D6-8B5C-8B4BF46BEAC4 Q26776041-563F039C-DCDF-44B9-A7AE-0767DA0D4ABD Q27024152-E99CBEF5-3344-42A6-9F73-DEA07A5C689A Q28206557-A69E0861-6E2D-4BFA-B58A-475A7527B909 Q30580687-E9B645AD-5D82-46C0-AEB8-D7D8CAEF074A Q30830441-EA2A3F70-004D-4D72-B11A-94B8D30C6F36 Q31118947-5A792FF2-8E0A-4931-899F-5209CC7FED0C Q33212017-B76C0B31-EC5C-4DCC-AB63-1663937B1B40 Q33565361-E3054650-E0D0-4945-A591-922301CAB367 Q33581952-C9D7711B-A51D-4121-83EF-99D22F27C62C Q33704308-6040AA46-F29B-4645-935F-0C0C357CA538 Q33791830-01C32E8A-3352-417B-8D4A-A2327AC25415 Q33816851-6FAA3167-0643-4060-83F8-0BED6B4F4561 Q34053847-5DBAF22E-A53D-4969-8153-56D25B539BE9 Q34075118-A7761536-F25E-4C5C-BA59-702CA0F9AEE7 Q34327144-AC627E25-F3C2-4BB4-BD31-83CCCB0E89E0 Q34371507-6D18FCB3-1A3A-47AA-BB8B-EB894F7240F0 Q34409502-F6D63897-E343-4711-BE9A-F980E92348E9 Q34476794-C50FF9E4-7C12-4F23-9D51-E77EC7FABADA Q34480963-F936363A-114A-434E-BE50-B35EEFEEE1D7 Q34710384-11BE15C6-9814-4D7F-BFDB-3F84B8C36165 Q34999790-BDEB711C-7AD1-4810-93DF-12231B015DEF Q35028568-7A11140A-FD70-4908-A2C9-C681346C9E13 Q35073054-1BB6335F-4476-4D25-95CF-0FF85F9DA3D2 Q35131249-F1D6005D-512C-44F5-B61A-2459E2AB2B8D Q35236822-8E88AFE4-A70E-4916-B4B6-105F0FDE0E4F Q35575249-A987119E-5937-4015-8790-F42321242ADD Q35648129-84E5D52A-FF04-4A59-84F0-5269335787E4 Q35648168-69B63842-68ED-4F75-B989-22FAB275111C Q35732928-AD59BB3B-3E23-40FD-8F5B-A66EB8F962B6 Q35736662-F4C6AD20-48FD-4AE5-8F99-BB0B0874C643 Q36045259-B06B0EF2-1DB1-43F9-9D9D-893526398472 Q36045402-9BFD4EF3-0FA3-4B34-B6D3-70CF7C85FDDB Q36273378-3FD8C26D-3ED2-425A-81C5-26E6117E1AAB Q36370618-C306661C-4ECC-4EA3-92F4-D1B2C0DCE32E Q36438745-A37A7902-6317-4F20-9545-3FE8183916ED Q36560830-6247CBDA-2F8C-4601-88F6-5F39A232AB00 Q36718204-ED2CF48B-C1BF-40EA-83C3-2C33C7D91F1A

P2860

Bilateral fetal mesencephalic grafting in two patients with parkinsonism induced by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)

http://www.wikidata.org/entity/Q28202629

description

1992 nî lūn-bûn

@nan

1992 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած

@hyw

1992 թվականի նոյեմբերին հրատարակված գիտական հոդված

@hy

1992年の論文

@ja

1992年論文

@yue

1992年論文

@zh-hant

1992年論文

@zh-hk

1992年論文

@zh-mo

1992年論文

@zh-tw

1992年论文

@wuu

name

Bilateral fetal mesencephalic ...... ,3,6-tetrahydropyridine (MPTP)

@ast

Bilateral fetal mesencephalic ...... ,3,6-tetrahydropyridine (MPTP)

@en

Bilateral fetal mesencephalic ...... ,3,6-tetrahydropyridine (MPTP)

@nl

type

label

Bilateral fetal mesencephalic ...... ,3,6-tetrahydropyridine (MPTP)

@ast

Bilateral fetal mesencephalic ...... ,3,6-tetrahydropyridine (MPTP)

@en

Bilateral fetal mesencephalic ...... ,3,6-tetrahydropyridine (MPTP)

@nl

prefLabel

Bilateral fetal mesencephalic ...... ,3,6-tetrahydropyridine (MPTP)

@ast

Bilateral fetal mesencephalic ...... ,3,6-tetrahydropyridine (MPTP)

@en

Bilateral fetal mesencephalic ...... ,3,6-tetrahydropyridine (MPTP)

@nl

P1433

Q28202629-26849766-CF2A-493E-A39D-85A1EFD2B2DF

P1476

Q28202629-FE7E7AFE-C6FF-4FDC-8F33-B8AE36500E20

P2093

Q28202629-0E34A032-1C53-4E7D-9C94-ECA607D0CF0C

Q28202629-234D722A-3651-4F44-8E28-68F9CEFD76C5

Q28202629-35E176B1-D23E-4A62-8017-4CB1868483CD

Q28202629-393CC839-AEF4-424D-A59F-424FB26B2238

Q28202629-75554EDC-631F-4FB4-95DE-A985BEDEB148

Q28202629-7C922DBE-85C1-49F4-A327-7FE3F792F315

Q28202629-93C377AD-DE02-4FAF-ADC1-50F174C2B401

Q28202629-C378AF99-1910-4B09-BF1C-160BBC6F07C9

P304

Q28202629-E8A80E3F-0DAD-42AE-9974-9B6A9CA50FCC

P31

Q28202629-A4B2AEBD-2754-4261-8546-3328E5DC9138

P356

Q28202629-A237326D-C804-4A4D-8D70-C13723E7D391

P407

Q28202629-5C97B36A-C9F5-4503-A9D3-20C815CD41DE

P433

Q28202629-22D5E58A-2777-480E-A426-8856F90AC4EB

P478

Q28202629-FC728300-0FD1-42AA-981E-2A13596B66AB

P50

Q28202629-AA41B731-1508-4D36-A660-57F8E4FE28C1

P577

Q28202629-6B220A42-EE56-4C26-91E1-39AB70A8BD95

P698

Q28202629-8F061336-3D45-4E4A-BD32-22108C9C010A

P921

Q28202629-3A957AC2-7BC6-4A4C-8591-5C793367772A

P356

NEJM199211263272203

P1433

The New England Journal of Medicine

P1476

Bilateral fetal mesencephalic ...... ,3,6-tetrahydropyridine (MPTP)

@en

P2093

B Gustavii

http://www.w3.org/2001/XMLSchema#string

B Snow

http://www.w3.org/2001/XMLSchema#string

H Widner

http://www.w3.org/2001/XMLSchema#string

J Tetrud

http://www.w3.org/2001/XMLSchema#string

J W Langston

http://www.w3.org/2001/XMLSchema#string

O Lindvall

http://www.w3.org/2001/XMLSchema#string

P Brundin

http://www.w3.org/2001/XMLSchema#string

S Rehncrona

http://www.w3.org/2001/XMLSchema#string

P304

1556-63

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1056/NEJM199211263272203

http://www.w3.org/2001/XMLSchema#string

P407

P433

22

http://www.w3.org/2001/XMLSchema#string

P478

327

http://www.w3.org/2001/XMLSchema#string

P50

Anders Björklund

P577

1992-11-26T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

1435882

http://www.w3.org/2001/XMLSchema#string

P921

Parkinson's disease